{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics, numeric values, and units."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text snippet provided does not contain any sentences with a specific molecule name, ID, or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text appears to describe general chemical structures and properties, but does not provide specific data or measurements."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs discussed above, preferred compounds of the invention exhibit activity in a prostaglandin DP<sub>1 </sub>receptor binding assay as described, for example in the protocol of Example 5 which follows. Generally preferred compounds of the invention have a Ki(\u03bcM) of about 100 or less, more preferably about 50 or less, still more preferably a Ki(\u03bcM) of about 10 or 20 or less, even more preferably a Ki(pM) of about 5 or less in such a prostaglandin assay as exemplified by Example 5 provided herein below.\nA particularly preferred group of DP<sub>1 </sub>receptor agonists of the invention have a Ki(nM) of about 20 or less, more preferably about 10 or less, still more preferably a Ki (nM) of about 5 or 2 or less, even more preferably a Ki(nM) of about 1 or less, further more preferred, a Ki(nM) of about 0.1 or less in a prostaglandin DP<sub>1 </sub>receptor binding assay as exemplified by Example 5 which follows.\nAnother particularly preferred group of DP<sub>1 </sub>receptor agonists of the invention have a EC<sub>50 </sub>(nM) of about 30 or less, more preferably about 20 or less, still more preferably a EC<sub>50 </sub>(nM) of about 10 or 5 or less, even more preferably a EC<sub>50</sub>(nM) of about 1 or 0.1 less in such a cAMP/DP<sub>1 </sub>receptor as exemplified by Example 5, which follows."}
{"final_json": [{"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "100", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "50", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "10", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "20", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "5", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "5", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "2", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "0.1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "30", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "5", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "prostaglandin DP1 receptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.1", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n* Using such an assay, the DP1 Ki values for a number of exemplary compounds of the present invention were calculated and are shown in Table 1, with K_i values for h-EP2, h-EP3 and h-EP4 of >10000 nM.\n* TABLE 1: Inhibition of DP1, h-DP2 K_i, h-DP1 K_i, h-DP1 EC50 (nM), including values such as 4.1 nM, 0.3 nM, 0.031 nM, 0.00072 nM, etc.\n* For cAMP assays, cells are harvested and resuspended in HBSS containing 25 mM HEPES, pH 7.4, and incubations contain 100 \u03bcM RO-20174, with EC50 values calculated.\n* For agonists, second messenger responses are expressed as a function of ligand concentration and both EC50 values, such as 0.71 nM, 1.38 nM, and 1.8 nM, and the maximum response as compared to a prostanoid standard are calculated.\n* In another exemplary protocol, HEK293-EBNA cells transfected with the appropriate receptors are seeded in 96 well opaque plate, and after 1 hour incubation, total cAMP is measured, with EC50 values determined, such as 0.3 nM, 0.031 nM, and 0.00072 nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "h-EP2, h-EP3, h-EP4", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "K_i", "value": ">10000", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "DP1, h-DP2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "K_i, EC50", "value": "4.1, 0.3, 0.031, 0.00072", "unit": "nM"}, {"molecule_name": "RO-20174", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.71, 1.38, 1.8", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.3, 0.031, 0.00072", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nGroup 25IU PMSGHCG (0.12 mg/kg i.p.)\nGroup 35IU PMSGPGE2 (13.5 mg/kg)\nGroup 45IU PMSGTest compound (10 mg/kg)\nGroup 55IU PMSGTest compound (30 mg/kg)\nGroup 65IU PMSGTest compound (90 mg/kg)\nAgonists of DP1 are selected using the assays described above on the basis of their Ki and/or EC50 values.\nThe compounds of the invention are then tested in the in vivo ovulation induction model as described above in order to calculated the ED50 for subcutaneous (s. c.) and oral (po) routes of administration.\nIn exemplary embodiments, oral activity in the in vivo model of ovulation induction is evaluated for other compounds of the invention at the single dose of 20 mg/kg.\npentobarbital sodium (50 mg/kg i.p., plus an additional 15 mg/kg i.p. if required) \nsuccinylcholine chloride (2 mg/animal i. p.)"}
{"final_json": [{"molecule_name": "PMSGHCG", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.12", "unit": "mg/kg"}, {"molecule_name": "PMSGPGE2", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "13.5", "unit": "mg/kg"}, {"molecule_name": "Test compound", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "mg/kg"}, {"molecule_name": "Test compound", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "30", "unit": "mg/kg"}, {"molecule_name": "Test compound", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "90", "unit": "mg/kg"}, {"molecule_name": null, "protein_target_name": "DP1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "DP1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "ED50", "value": null, "unit": null}, {"molecule_name": "Test compound", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "20", "unit": "mg/kg"}, {"molecule_name": "pentobarbital sodium", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "50", "unit": "mg/kg"}, {"molecule_name": "pentobarbital sodium", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "15", "unit": "mg/kg"}, {"molecule_name": "succinylcholine chloride", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "2", "unit": "mg/animal"}]}
